Model 1: Crude, Model 2: Further adjusted for age, Model 3: Further adjustment for BMI and physical activity, smoking, and alcohol drinking, Model 4: Further adjusted for calorie intake
18,122 It deacetylates STAT4, reducing its activity and inhibiting Th1 differentiation, which decreases IFN- production and mitigates KC activation
Plaintiff Geoffrey Symonds claims he developed NAION after using Ozempic for less than three months, from November 2021 to January 2022
No significant correlation was found between metabolite levels and hyper/impulsive scores of ADHD, measures of core ASD symptoms (ADOS-2, SRS-P) or adaptive behavior (ABAS-2)
Hernandez AF, Green JB, Janmohamed S, DAgostino RB, Granger CB, Jones NP, Leiter LA, Rosenberg AE, Sigmon KN, Somerville MC
The combination Qsymia (phentermine + topiramate) is a separate FDA-approved medication that pairs a low-dose stimulant with an anti-seizure drug but even Qsymia produces less weight loss than semaglutide alone (10% vs 15%)